tocilizumab monotherapy

DRUG4 trials

Sponsors

Department of Rheumatology & Clinical Immunology,Saitama Medical Center, Saitama Medical Universitity, Department of Rheumatology & Clinical Immunology Saitama Medical Center, Saitama Medical Universitity, Saitama Medical Center, Saitama Medical University Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital

Conditions

Chronic PeriaortitisMicroscopic polyangiitisRheumatoid arthritisTocilizumab Monotherapy

Unknown Phase

Efficacy and safety of tocilizumab mono-therapy in patients with adult-onset Still's disease

Active, not recruitingJPRN-UMIN000007019

Department of Rheumatology & Clinical Immunology,Saitama Medical Center, Saitama Medical UniversitityRheumatoid arthritis

Start: 2012-02-01Target: 40Updated: 2026-06-29

Efficacy and safety of tocilizumab mono-therapy in patients with large vessel vasculitis (LVV; giant cell arteritis or Takayasu arteritis) and polymyalgia rheumatica (PMR)

Active, not recruitingJPRN-UMIN000008812

Department of Rheumatology & Clinical Immunology Saitama Medical Center, Saitama Medical UniversitityRheumatoid arthritis

Start: 2012-10-01Target: 40Updated: 2026-06-29

Efficacy and safety of tocilizumab monotherapy in patients with microscopic polyangiitis

Active, not recruitingJPRN-UMIN000011242

Saitama Medical Center, Saitama Medical University Department of Rheumatology and Clinical ImmunologyMicroscopic polyangiitis

Start: 2013-09-01Target: 10Updated: 2026-06-29

Pilot Study of Tocilizumab Monotherapy for Active Chronic Periaortitis

CompletedNCT05133895

Peking Union Medical College HospitalChronic Periaortitis, Tocilizumab Monotherapy

Start: 2020-07-15End: 2022-12-30Updated: 2023-03-02